Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NexgenRx ( (TSE:NXG) ) just unveiled an announcement.
NexgenRx has reported significant financial growth in the second quarter of 2025, with a revenue increase of $349,043, marking an 8.73% rise compared to the previous year. The company’s EBITDA also saw a positive increase, supported by strong recurring revenues and a robust sales pipeline. A major new client acquisition in April has further solidified NexgenRx’s market position, demonstrating the company’s commitment to exceeding customer expectations through innovation and teamwork. This growth positions NexgenRx well for continued value creation for clients, employees, and shareholders.
More about NexgenRx
NexgenRx is Canada’s only independent full-service Third-Party Administrator and Technology Solutions Provider. The company offers proprietary front-end, eligibility, enrolment, hour bank, and mobile access capabilities, along with state-of-the-art claims adjudication and full provider network coverage. These services are provided in a cost-effective SaaS model, catering to Plan Sponsors with sophisticated administration and health benefit technology applications.
Average Trading Volume: 21,329
Technical Sentiment Signal: Buy
Current Market Cap: C$26.31M
Learn more about NXG stock on TipRanks’ Stock Analysis page.